On September 23, 2021, the module 6 of the phase I of Pharmaceutical and Health Enterprise Leading CTO Career Breakthrough Class was successfully carried out in Shanghai International School of Chief Technology Officer (hereinafter referred to as “CTO School”).
Nearly 40 guests and students from ACERAND Biomedicines, Shanghai Symray Biopharma, Shanghai Oebiotech Medical Technology Co., Ltd., KPMG, Anjie Law Firm, GreenMorrow Investment Funds and other enterprises and institutions visited the three famous pharmaceutical enterprises and institutions in the Suzhou Industrial Park, namely Innovent Biologics (Suzhou) Co., Ltd., Suzhou Abogen Biosciences and Suzhou Institute of Systems Medicine, closely observed the technological progress and commercialization process in China’s pharmaceutical field and deeply understood the operating characteristics of biopharmaceutical enterprises and the latest trends in the industry.
